Home > Drug Search >
  • company_query: Atara Biotherapeutics
  •   > 
Drug Filter
Category:
chemistry (10) biology (20)
Status:
Approved (9) NDA Filing (2) Phase Ⅲ (2) Phase Ⅱ (10) Phase Ⅰ (6)
Clinical Stage:
Pending (2) Active (13) Discontinued (6)
Bio-Type:
Cell therapy (2) CAR T cell therapy (1) Vaccine (2) Blood extraction (3) Recombinant enzyme (1) Recombinant cytokines (2) Other recombinant protein (2) Fusion protein (3)
Indication:
Acute myeloid Leukemia (AML) (1) Asthma (1) Breast cancer (1) Candidiasis (1) Chronic obstructive pulmonary disease (COPD) (1) Cystic fibrosis (CF) (2) Dry eye disease (1) Endometrial cancer (1) Erectile dysfunction (ED) (1) Female sexual dysfunction (1) Cytomegalovirus infections (1) HCV infection (1) EBV-associated post-transplant lymphoproliferative disease (PTLD) (1) Alcoholic hepatitis (1) Hepatocellular carcinoma (HCC) (1) Hypovolemia (1) Hypoalbuminemia (1) Ovarian hyperstimulation syndrome (OHSS) (1) Adult respiratory distress syndrome (ADRS) (1) Cardiopulmonary bypass (1) Chemotherapy-induced thrombocytopenia (1) Hypertension (1) Chronic inflammatory demyelinating polyradiculoneuropathy (1) Rabies (1) Type I plasminogen deficiency (1) Leukemia (1) Malignancies (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (1) Non-Hodgkin B-cell lymphomas (1) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (1) Solid tumours (2) Vaginal candidiasis (1) Tinea versicolor (1) Stroke (1) Neutropenia (1) Glioma (2) Graft versus host disease (1) Burns (1) Immunodeficiency disorders (1) Ebola virus disease (EVD) (2) Seborrhoeic dermatitis (1) Skin disorders (1) Immune thrombocytopenic purpura (1)
Country:
Aprv. Year:
2008 (1) 2011 (1) 2012 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top